Reviews - Specialty Releases


Film Review: Orgasm Inc.

Hardly the recent lame finger-wagging that gooey rom-com Love and Other Drugs gave naughty drug giants, Liz Canner’s documentary gives the finger as she exposes certain billion-dollar pharmaceutical firms and other opportunists in their embrace of the dubious “Female Sexual Dysfunction” disorder.

Feb 9, 2011

-By Doris Toumarkine


filmjournal/photos/stylus/1208928-Orgasm_Md.jpg

For movie details, please click here.

Contrary to some publicity material for Liz Canner’s important documentary Orgasm Inc., this filmmaker’s first feature documentary does not “explore the strange science of female pleasure.” In fact, there’s no significant exploration of cause, effect or map to that mysterious pleasure plateau or to the impact sexual orientation surely has. (Childhood abuse does get a cursory mention.)

What her entertaining film does do is, uh, penetrate the exploitative, money-driven worlds of certain corporate giants (e.g., Pfizer, Procter & Gamble), their dubious sexologist, psychologist, plastic surgery and academic boosters (notably Chicago-based sex therapist/celeb/franchise builder Dr. Laura Berman) and sex product start-ups (Vivus and founder Virgil Place, who invited doctors on a luxury Utah ski trip to push their product), inventors (like those behind the failed Orgasmatron gizmo), academics (Harvard Medical School’s wishy-washy Susan Bennett), and sales staffers (like the self-doubting Lisa, who guiltily promotes genital surgery but covets a new job).

These proselytizers all toy with the notion of Female Sexual Dysfunction (FSD), a catchy if possibly spurious label to a freshly minted “disease.” And then there’s that Holy Grail (i.e., money tree) to grab onto—a Viagra for women.

The disorder, arguably more controversial and suspect than CFS (Chronic Fatigue Syndrome), is how this greedy, orgasm-for-all gang brand women who have trouble reaching climax with a sex partner. Like sexual orientation, masturbation is another sidelined issue, as is the role of fantasy and porn. (Heck, even the Kids Are All Right ladies hopped with delight on the fantasy/male porn bandwagon to stimulate arousal.)

While pleasure has little to do with things here, the doc does, in an Inside Job kind of way, make the phalanx of opportunistic FSD proponents look downright embarrassing and mercenary. The not-so-faint aroma of charlatanism evokes Frank Morgan’s snake oil salesman in The Wizard of Oz.

Orgasm Inc., whose animation segments of drugs racing to FDA approval amuse, also has its way with the orgasm-challenged themselves, most prominent of whom is the generously forthcoming Charlotta, a soldiering Southern lady of a certain age who’s downright determined to get her mojo up and running. Alas, one of more highly touted new products just doesn’t cut it.

There are hints that blood flow or lack thereof is central to the female orgasm, but this too is left unaddressed. Canner leaves the mystery of orgasm intact but makes those pushing FSD and its seemingly bogus “cures” appear silly. On the side of sanity and intelligence are New York University psychology professor/sex therapist Leonore Tiefer and Australian activist Ray Moynihan, who believes the FSD movement is “turning healthy people into patients.”

The film kicks off with Canner hired to edit erotic videos to be used in a drug trial for Vivus, a pharmaceutical company hoping to get FDA approval for its "Viagra" drug for women afflicted with this new FSD disease. No dummy, she soon suspects that her employer, along with other medical and pharmaceutical companies, might be trying to take advantage of women (and potentially endanger their health) in pursuit of profit. The company’s Boston-based female expert on pornography does not instill confidence.

Canner’s access, of course, pays off. Over nine years she follows pharmaceutical companies and medical device manufacturers who are racing to be the first to win FDA approval for their products, whether pill, patch, nose spray, gizmo, whatever (even something digital can’t solve the problem). Billions of dollars are at stake, as is a concept of “normal sexual function” and orgasm, neither of which the doc tries to define.

Rather, Canner’s doc, uh, climaxes with a triumphant FDA hearing that derails yet another of corporate America’s wet dreams for a female Viagra. Her exposé of what big business and hungry wannabes and hangers-on do best—exploit fears, insecurities and myths at the expense of others and to their own enrichment—is familiar except for its ingenious exploitation of the female orgasm.


Film Review: Orgasm Inc.

Hardly the recent lame finger-wagging that gooey rom-com Love and Other Drugs gave naughty drug giants, Liz Canner’s documentary gives the finger as she exposes certain billion-dollar pharmaceutical firms and other opportunists in their embrace of the dubious “Female Sexual Dysfunction” disorder.

Feb 9, 2011

-By Doris Toumarkine


filmjournal/photos/stylus/1208928-Orgasm_Md.jpg

For movie details, please click here.

Contrary to some publicity material for Liz Canner’s important documentary Orgasm Inc., this filmmaker’s first feature documentary does not “explore the strange science of female pleasure.” In fact, there’s no significant exploration of cause, effect or map to that mysterious pleasure plateau or to the impact sexual orientation surely has. (Childhood abuse does get a cursory mention.)

What her entertaining film does do is, uh, penetrate the exploitative, money-driven worlds of certain corporate giants (e.g., Pfizer, Procter & Gamble), their dubious sexologist, psychologist, plastic surgery and academic boosters (notably Chicago-based sex therapist/celeb/franchise builder Dr. Laura Berman) and sex product start-ups (Vivus and founder Virgil Place, who invited doctors on a luxury Utah ski trip to push their product), inventors (like those behind the failed Orgasmatron gizmo), academics (Harvard Medical School’s wishy-washy Susan Bennett), and sales staffers (like the self-doubting Lisa, who guiltily promotes genital surgery but covets a new job).

These proselytizers all toy with the notion of Female Sexual Dysfunction (FSD), a catchy if possibly spurious label to a freshly minted “disease.” And then there’s that Holy Grail (i.e., money tree) to grab onto—a Viagra for women.

The disorder, arguably more controversial and suspect than CFS (Chronic Fatigue Syndrome), is how this greedy, orgasm-for-all gang brand women who have trouble reaching climax with a sex partner. Like sexual orientation, masturbation is another sidelined issue, as is the role of fantasy and porn. (Heck, even the Kids Are All Right ladies hopped with delight on the fantasy/male porn bandwagon to stimulate arousal.)

While pleasure has little to do with things here, the doc does, in an Inside Job kind of way, make the phalanx of opportunistic FSD proponents look downright embarrassing and mercenary. The not-so-faint aroma of charlatanism evokes Frank Morgan’s snake oil salesman in The Wizard of Oz.

Orgasm Inc., whose animation segments of drugs racing to FDA approval amuse, also has its way with the orgasm-challenged themselves, most prominent of whom is the generously forthcoming Charlotta, a soldiering Southern lady of a certain age who’s downright determined to get her mojo up and running. Alas, one of more highly touted new products just doesn’t cut it.

There are hints that blood flow or lack thereof is central to the female orgasm, but this too is left unaddressed. Canner leaves the mystery of orgasm intact but makes those pushing FSD and its seemingly bogus “cures” appear silly. On the side of sanity and intelligence are New York University psychology professor/sex therapist Leonore Tiefer and Australian activist Ray Moynihan, who believes the FSD movement is “turning healthy people into patients.”

The film kicks off with Canner hired to edit erotic videos to be used in a drug trial for Vivus, a pharmaceutical company hoping to get FDA approval for its "Viagra" drug for women afflicted with this new FSD disease. No dummy, she soon suspects that her employer, along with other medical and pharmaceutical companies, might be trying to take advantage of women (and potentially endanger their health) in pursuit of profit. The company’s Boston-based female expert on pornography does not instill confidence.

Canner’s access, of course, pays off. Over nine years she follows pharmaceutical companies and medical device manufacturers who are racing to be the first to win FDA approval for their products, whether pill, patch, nose spray, gizmo, whatever (even something digital can’t solve the problem). Billions of dollars are at stake, as is a concept of “normal sexual function” and orgasm, neither of which the doc tries to define.

Rather, Canner’s doc, uh, climaxes with a triumphant FDA hearing that derails yet another of corporate America’s wet dreams for a female Viagra. Her exposé of what big business and hungry wannabes and hangers-on do best—exploit fears, insecurities and myths at the expense of others and to their own enrichment—is familiar except for its ingenious exploitation of the female orgasm.
Post a Comment
Asterisk (*) is a required field.
* Author: 
Rate This Article: (1=Bad, 5=Perfect)

*Comment:
 

More Specialty Releases

E-Team
Film Review: E-Team

Four international human rights investigators descend on political atrocities to determine accountability. More »

Laggies
Film Review: Laggies

Disappointing comedic entry about a late-20s slacker who won’t grow up is writer/filmmaker Lynn Shelton’s first outing directing someone else’s material. Points here for strong cast and an occasional chuckle, but otherwise there’s just no point. More »

Rudderless
Film Review: Rudderless

Well-done indie drama about a lost-soul house painter reborn through rock ’n’ roll is a nice actor’s showcase for star Billy Crudup and an impressive directorial debut for actor William H. Macy. But in spite of some good work onscreen, both hero and story lack the edge and originality to carry this drama beyond respectability. More »

Camp X-Ray
Film Review: Camp X-Ray

Army guard and Guantanamo detainee form a grudging relationship in a thoughtful but far-fetched drama. More »

ADVERTISEMENT



REVIEWS

Fury Review
Film Review: Fury

American tanks fight superior German forces in the closing days of World War II. More »

Birdman
Film Review: Birdman (or the Unexpected Virtue of Ignorance)

Virtuosic camerawork and a stellar ensemble of actors more than make up for the occasional moment of portentous twaddle in Alejandro G. Iñárritu's latest—and maybe his best—film. More »

Player for the Film Journal International website.


ADVERTISEMENT



INDUSTRY GUIDES

» Blue Sheets
FJI's guide to upcoming movie releases, including films in production and development. Check back weekly for the latest additions.

» Distribution Guide
» Equipment Guide
» Exhibition Guide

ORDER A PRINT SUBSCRIPTION

Film Journal International

Subscribe to the monthly print edition of Film Journal International and get the full visual impact of this valuable resource for the cinema business.

» Click Here

SPONSORSHIP OPPORTUNITIES

Learn how to promote your company at the Film Expo Group events: ShowEast, CineEurope, and CineAsia.

» Click Here